Aida Rahmani Mashhour

Aida Rahmani Mashhour

Auto-generated profile, based on publicly available information

Aida Rahmani Mashhour

Center for Free-Electron Laser Science CFEL, Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Science
Verified
Journal Article
Closed access
NCNina-Eleni Christou
Nina-Eleni Christou
VAVirginia Apostolopoulou
Virginia Apostolopoulou
DMDiogo V. M. Melo
Diogo V. M. Melo
MRMatthias Ruppert
Matthias Ruppert
AFAlisia Fadini
Alisia Fadini
TLThomas J. Lane
Thomas J. Lane
Photolyase is an enzyme that uses light to catalyze DNA repair. To capture the reaction intermediates involved in the enzyme’s catalytic cycle, we conducted a time-resolved crystallography experiment. We found that photolyase traps the excited state of the active cofactor, flavin adenine dinucleotide (FAD), in a highly bent geometry. This excited state performs electron transfer to damaged DNA, inducing repair. We show that the repair reaction, which involves the lysis of two covalent bonds, occurs through a single-bond intermediate. The transformation of the substrate into product crowds the active site and disrupts hydrogen bonds with the enzyme, resulting in stepwise product release, with the 3′ thymine ejected first, followed by the 5′ base.

18 October 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
PRPatrick Y. A. Reinke
Patrick Y. A. Reinke
ESEdmarcia Elisa de Souza
Edmarcia Elisa de Souza
SGSebastian Guenther
Sebastian Guenther
SFSven Falke
Sven Falke
JLJulia Lieske
Julia Lieske
AMAlke Meents
Alke Meents
Several drug screening campaigns identified Calpeptin as a drug candidate against SARS-CoV-2. Initially reported to target the viral main protease (Mpro), its moderate activity in Mpro inhibition assays hints at a second target. Indeed, we show that Calpeptin is an extremely potent cysteine cathepsin inhibitor, a finding additionally supported by X-ray crystallography. Cell infection assays proved Calpeptin’s efficacy against SARS-CoV-2. Treatment of SARS-CoV-2-infected Golden Syrian hamsters with sulfonated Calpeptin at a dose of 1 mg/kg body weight reduces the viral load in the trachea. Despite a higher risk of side effects, an intrinsic advantage in targeting host proteins is their mutational stability in contrast to highly mutable viral targets. Here we show that the inhibition of cathepsins, a protein family of the host organism, by calpeptin is a promising approach for the treatment of SARS-CoV-2 and potentially other viral infections.

28 November 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
LWLainey Williamson
Lainey Williamson
MGMarina Galchenkova
Marina Galchenkova
HBHannah Louise Best
Hannah Louise Best
RBRichard Bean
Richard Bean
Anna MunkeAnna Munke
Anna Munke
DODominik Oberthür
Dominik Oberthür
The Lysinibacillus sphaericus proteins Tpp49Aa1 and Cry48Aa1 can together act as a toxin toward the mosquito Culex quinquefasciatus and have potential use in biocontrol. Given that proteins with sequence homology to the individual proteins can have activity alone against other insect species, the structure of Tpp49Aa1 was solved in order to understand this protein more fully and inform the design of improved biopesticides. Tpp49Aa1 is naturally expressed as a crystalline inclusion within the host bacterium, and MHz serial femtosecond crystallography using the novel nanofocus option at an X-ray free electron laser allowed rapid and high-quality data collection to determine the structure of Tpp49Aa1 at 1.62 Å resolution. This revealed the packing of Tpp49Aa1 within these natural nanocrystals as a homodimer with a large intermolecular interface. Complementary experiments conducted at varied pH also enabled investigation of the early structural events leading up to the dissolution of natural Tpp49Aa1 crystals—a crucial step in its mechanism of action. To better understand the cooperation between the two proteins, assays were performed on a range of different mosquito cell lines using both individual proteins and mixtures of the two. Finally, bioassays demonstrated Tpp49Aa1/Cry48Aa1 susceptibility of Anopheles stephensi , Aedes albopictus, and Culex tarsalis larvae—substantially increasing the potential use of this binary toxin in mosquito control.

7 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
PRPatrick Y. A. Reinke
Patrick Y. A. Reinke
RSRobin Schubert
Robin Schubert
DODominik Oberthür
Dominik Oberthür
MGMarina Galchenkova
Marina Galchenkova
AMAida Rahmani Mashhour
Aida Rahmani Mashhour
TLThomas J. Lane
Thomas J. Lane
The main protease (Mpro) of SARS-CoV-2 is critical for viral function and a key drug target. Mpro is only active when reduced; turnover ceases upon oxidation but is restored by re-reduction. This suggests the system has evolved to survive periods in an oxidative environment, but the mechanism of this protection has not been confirmed. Here, we report a crystal structure of oxidized Mpro showing a disulfide bond between the active site cysteine, C145, and a distal cysteine, C117. Previous work proposed this disulfide provides the mechanism of protection from irreversible oxidation. Mpro forms an obligate homodimer, and the C117-C145 structure shows disruption of interactions bridging the dimer interface, implying a correlation between oxidation and dimerization. We confirm dimer stability is weakened in solution upon oxidation. Finally, we observe the protein’s crystallization behavior is linked to its redox state. Oxidized Mpro spontaneously forms a distinct, more loosely packed lattice. Seeding with crystals of this lattice yields a structure with an oxidation pattern incorporating one cysteine-lysine-cysteine (SONOS) and two lysine-cysteine (NOS) bridges. These structures further our understanding of the oxidative regulation of Mpro and the crystallization conditions necessary to study this structurally.

2 May 2026 in Communications Biology
Verified
Journal Article
Open access
ACAnne Creon
Anne Creon
TST. Emilie S. Scheer
T. Emilie S. Scheer
PRPatrick Reinke
Patrick Reinke
AMAida Rahmani Mashhour
Aida Rahmani Mashhour
SGSebastian Guenther
Sebastian Guenther
TLThomas J. Lane
Thomas J. Lane
To interpret and transmit biological signals, proteins use correlated motions. Experimental determination of these dynamics and the structural distributions they generate remains a key challenge. Here, using 1146 crystal structures of the main protease (M pro ) from SARS-CoV-2, we were able to infer a model of the enzyme’s structural fluctuations. M pro is regulated by concentration, becoming enzymatically active after forming a homodimer. To understand the structural changes that enable dimerization to activate catalysis, we employed our model, predicting which regions of the dimerization domain are structurally correlated with the active site. Mutations at these positions, expected to disrupt catalysis, resulted in a dramatic reduction in activity in one case, a mild effect in the second, and none in the third. Additional crystallography and biophysical experiments provide a mechanistic explanation for these results. Our work suggests that a statistical crystallography, in which numerous crystallographic datasets are analyzed, can reveal the structural fluctuations of protein native states and help uncover their biological function.